Ingasalin solution hypertonic steril. 3%, 5ml # 10

Diseases of the respiratory system, which are accompanied by difficult separation of viscous secretions (sputum) in the airways:

• acute bronchitis;

• exacerbation of chronic bronchitis;

• bronchiectasis;

• cystic fibrosis.

Any jet or membrane nebulizer is recommended. For IngasalinЃ solution, you can use an ultrasonic inhaler (for example, an ultrasonic inhaler SOLOPHARM NM211E).

Breathing should be at a normal pace during inhalation therapy, which lasts about 10 minutes.

For inhalation, use a solution at room temperature.

Apply 1 ampoule (4 or 5 ml) of solution 2 times / day or according to the doctor's prescription. Treatment can be started with a smaller amount of solution and the dose can be increased gradually.

The procedure for working with the solution

1. Before using the solution, it is necessary to read the instructions of the manufacturer of the nebulizer.

2. Prepare the nebulizer according to the manufacturer's instructions.

3. Take the ampoule and shake it, holding the neck

4. Squeeze the ampoule with your hand, while there should be no release of the solution, and rotate and separate the valve with rotating movements

5. Squeeze the solution into the nebulizer reservoir

6. Use the nebulizer according to the manufacturer's instructions.

7. Solution left unused in the nebulizer chamber should be discarded immediately after each use.

8. Thoroughly wash the nebulizer.

The instructions for use, maintenance and cleaning of the nebulizer must be followed.

Solution for inhalation hypertonic sterile 3% transparent, colorless or slightly colored.

1 ml

sodium hyaluronate 0.1 mg

sodium chloride 30 mg

Excipients: water d / i - up to 1 ml.

Contains no preservatives.

Hypersensitivity to the components of the solution.

Properties

IngasalinЃ solution is designed to accelerate the discharge of viscous secretions (sputum) in the respiratory tract due to the osmotic mechanism. The high salt concentration attracts water and helps rehydrate bronchial mucus.

Hyaluronic acid (sodium hyaluronate) - a component in the IngasalinЃ product, has the ability to bind a large number of water molecules and keep them in the interfibrillar space, participates in defense mechanisms, stimulating the movement of cilia, protects lung tissue from the harmful effects of enzymes.

Due to the presence of hyaluronic acid in the IngasalinЃ product, the patient's tolerance and adherence to therapy is significantly improved.

IngasalinЃ is especially indicated for patients with cystic fibrosis and bronchiectasis.

The medical device IngasalinЃ is intended for independent use at home, as well as for use in medical institutions.

Side effects

Possibly: allergic reactions.

Application during pregnancy and lactation

There is no data on the use of IngasalinЃ during pregnancy and during breastfeeding.

special instructions

The solution belongs to the products of individual and single use.

IngasalinЃ is intended for inhalation only.

The first application of the solution should take place under the supervision of a physician or qualified personnel.

The use of the solution by children should be under the supervision of an adult.

For people who are especially sensitive to the solution, at the beginning of treatment, premedication with bronchodilators is recommended, which help prevent bronchospasmodic reactions. Premedication with bronchodilators should be carried out under the supervision of a physician.

In the event of an attack of bronchospasm or persistent coughing, the patient must interrupt treatment and inform the attending physician.

Do not use the solution if, during the first opening of the ampoule, it was noticed that it was damaged or not tightly closed.

Do not reuse the remaining contents of the ampoule.

Do not mix hypertonic solution with other drugs.

Disposal procedure

It is allowed to dispose of the product (including unused solution) in accordance with SanPiN 2.1.7.2790 as class A waste (epidemiologically safe waste, close in composition to solid domestic waste).

Influence on the ability to drive vehicles and mechanisms

The effect on the ability to drive vehicles, operate machinery and engage in other potentially hazardous activities is unlikely if the solution is used correctly.

IngasalinЃ does not belong to products that can affect the psychomotor state of a person.